. Demographic Health Surveys (DHS) malaria module extract. Figure S2. Multiple Indicator Cluster Survey (MICS) malaria module extract.
. (A) Country-level intercept for chloroquine (CQ) use (fixed effect intercept plus random effect intercept). (B) Country-level slope (fixed effect slope plus random effect slope). On (A) and (B), the red dashed line represents the fixed effect intercept and slope, respectively, and hence separates countries with a positive random effect (to the right of the red line) and countries with a negative random effect. The black horizontal lines give the 95% confidence intervals for the parameters. The model parameter estimates, standard errors, and P values are given in Supplemental  Table 3 . The order of countries is determined by the level of their CQ use in 1999, as reflected by their intercept in the mixed effects model. In (A), countries like Malawi and Ethiopia with low (or no) CQ use in 1999 have a very negative intercept, whereas countries that started with higher CQ use have a larger intercept. In (B), the slopes of the decline in CQ use over the period from 1999 to 2011 are depicted. Countries like Rwanda and Kenya with a strong negative slope, reduced CQ use most rapidly, whereas those that show a larger slope (to the right of the fixed effect, shown in the red dashed line) reduced CQ use at a slower rate. The more negative the slope, the faster the rate at which CQ use declined post 1999. Table 4 gives the model parameter estimates, standard errors, and P values. In (A), countries with the lowest reported CQ use at the time of policy change are at the top of the figure and have negative random effects intercepts (to the left of the fixed effect, shown in the red dashed line); those with higher CQ use have higher intercepts (i.e., above the fixed effect). In (B), country-level slopes that indicate the temporal trends in CQ use in each country post policy change are shown. The more negative the slope, the faster the rate at which CQ use declined post policy change. Countries are ordered by increasing intercept in the mixed effect output. Supplemental Table 5 . In (B), the more negative the slope, the faster the rate at which SP use declined post 1999. Figure S9 . Time plot of the proportion of fever cases that were treated with artemisinin combination therapy (ACT). Shading is indicative of usage. 
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